x
A Pillar of Good Health
Why Skin Healing Matters
The Body's Largest Organ
15%
Of your total body weight, acting as our primary frontline shield.
Massive Need
84M+
Americans currently suffering from some form of skin disease.
High Risk Factor
1 in 4
Americans will develop skin cancer or suffer from a chronic wound, demanding earlier & better diagnostics.
Total Market Size
$60.5B+
Combined TAM for skin malignancies, acute/chronic wounds, & facial cosmetics.
Safe Biopsy
The Diapeutic Difference
High Quality Samples are the Key to Accuracy
Our sample collection system functions therapeutically, diagnostically and as quality control. In the case of wound care, we can debride, prep the wound bed and remove the biofilm getting directly to the source of the host molecular response.
Innovative Sample Collection Technology
We have exclusive access to Kylon® medical fabric, a patented technology that has demonstrated superiority in debridement, wound bed prep and biopsy1,2.
1. Kimble 2026 – Kylon® sampling technology provides superior biopsy
2. Rahimian 2026 – Kylon® vs. flocked swabs for infection detection.
Advanced Molecular Analysis with Machine Learning
Expertly curated biomarker panels and analysis technology enables detailed and specific assessment of the biological environment.
What We offer
Advanced Diagnostics and Therapeutics
Gentle Tissue Sampling
Precise and effective sampling tools enable best-in-class sample quality which is the foundation of good anaytics.
Molecular Analysis
Expertly curated biomarker panels and analysis technology enables detailed and specific assessment of the biological environment.
Personalized therapies
Individualized analysis yields therapies that are tuned to the unique patient circumstances.
Interesting Numbers in Wound Care
0,000
Amputations / Year
0M
People suffer from chronic wounds
$0B